Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-16
DOI: 10.2147/dddt.s608659 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Bing-Wei Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of general Medicine, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian…. Hauptthemen laut MEDLINE: Indoles, Quinolines, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of general Medicine, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of Ch…
- Department of Cardiothoracic Surgery, General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group, Fushun, Liaoning, People's Republic of China.
- Department of Pulmonology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of China.
- Department of Thoracic surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of Ch…
Zitieren
APA
Lu, B. W., Zhao, C., Wang, D. Z., & Wang, W. (2026). Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s608659
Vancouver
Lu BW, Zhao C, Wang DZ, Wang W. Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s608659
BibTeX
@article{Lu2026,
author = {Lu, Bing-Wei and Zhao, Can and Wang, Da-Zhong and Wang, Wei},
title = {Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--16},
doi = {10.2147/dddt.s608659}
}
EUVIMED